Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0093 | 0.0813 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-40 | 0.006 | 0.0368 | 0.0383 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0035 | 0.0025 | 0.0029 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0059 | 0.035 | 0.0406 |
Brugia malayi | Nuclear hormone receptor family member nhr-49 | 0.006 | 0.0368 | 0.0368 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 0.035 | 0.5 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.006 | 0.0368 | 0.0399 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.006 | 0.0368 | 0.0368 |
Schistosoma mansoni | thyroid hormone receptor | 0.0435 | 0.5454 | 0.6323 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.006 | 0.0368 | 0.0427 |
Echinococcus granulosus | Nuclear hormone receptor family member nhr 41 | 0.006 | 0.0368 | 0.0399 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0048 | 0.0207 | 0.0216 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0084 | 0.0687 | 0.8342 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.006 | 0.0368 | 0.0368 |
Trypanosoma brucei | trypanothione reductase | 0.0037 | 0.0049 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0048 | 0.0207 | 0.0207 |
Schistosoma mansoni | nuclear receptor 2DBD-gamma | 0.006 | 0.0368 | 0.0427 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0084 | 0.0687 | 0.8342 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 0.035 | 0.5 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.006 | 0.0368 | 0.5 |
Echinococcus granulosus | COUP TF:Svp nuclear hormone receptor | 0.006 | 0.0368 | 0.0399 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.0025 | 0.0029 |
Plasmodium falciparum | glutathione reductase | 0.0037 | 0.0049 | 0.5 |
Echinococcus multilocularis | FTZ F1 nuclear receptor protein | 0.006 | 0.0368 | 0.0399 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 0.035 | 0.5 |
Onchocerca volvulus | 0.006 | 0.0368 | 0.5 | |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.006 | 0.0368 | 0.0399 |
Schistosoma mansoni | RAR-like nuclear receptor | 0.006 | 0.0368 | 0.0427 |
Schistosoma mansoni | thyroid hormone receptor | 0.0435 | 0.5454 | 0.6323 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0368 | 0.0383 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0093 | 0.0813 | 1 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.006 | 0.0368 | 0.5 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.006 | 0.0368 | 0.0368 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0368 | 0.0383 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0025 | 0.5 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0375 | 0.4637 | 0.5363 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0084 | 0.0687 | 0.8342 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-41 | 0.006 | 0.0368 | 0.0383 |
Loa Loa (eye worm) | nuclear hormone receptor-like 1 | 0.0741 | 0.9615 | 1 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0084 | 0.0687 | 0.8342 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0037 | 0.0049 | 0.0051 |
Echinococcus granulosus | FTZ F1 nuclear receptor protein | 0.006 | 0.0368 | 0.0399 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0368 | 0.0383 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-14 | 0.006 | 0.0368 | 0.0383 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0059 | 0.035 | 0.3941 |
Brugia malayi | Nuclear hormone receptor family member nhr-1 | 0.006 | 0.0368 | 0.0368 |
Echinococcus multilocularis | COUP TF:Svp nuclear hormone receptor | 0.006 | 0.0368 | 0.0399 |
Brugia malayi | Nuclear hormone receptor family member nhr-31 | 0.006 | 0.0368 | 0.0368 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0037 | 0.0049 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0375 | 0.4637 | 0.5376 |
Echinococcus granulosus | hepatocyte nuclear factor 4 alpha | 0.006 | 0.0368 | 0.0399 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0048 | 0.0207 | 0.0207 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0368 | 0.0383 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0037 | 0.0056 | 0.0036 |
Schistosoma mansoni | nuclear hormone receptor nor-1/nor-2 | 0.006 | 0.0368 | 0.0427 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.006 | 0.0368 | 0.0368 |
Brugia malayi | steroid hormone receptor | 0.006 | 0.0368 | 0.0368 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0093 | 0.0813 | 1 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.006 | 0.0368 | 0.0368 |
Brugia malayi | nuclear receptor NHR-88 | 0.006 | 0.0368 | 0.0368 |
Loa Loa (eye worm) | steroid hormone receptor | 0.006 | 0.0368 | 0.0383 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0084 | 0.0687 | 0.8342 |
Brugia malayi | photoreceptor-specific nuclear receptor | 0.006 | 0.0368 | 0.0368 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0368 | 0.0383 |
Schistosoma mansoni | FTZ-F1 nuclear receptor-like protein | 0.006 | 0.0368 | 0.0427 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0059 | 0.035 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-1 | 0.006 | 0.0368 | 0.0383 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0668 | 0.8626 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-31 | 0.006 | 0.0368 | 0.0383 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0059 | 0.035 | 0.0406 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.006 | 0.0368 | 0.0368 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0025 | 0.5 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.0741 | 0.9615 | 0.9615 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0025 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0368 | 0.0383 |
Loa Loa (eye worm) | hypothetical protein | 0.0738 | 0.9569 | 0.9952 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0037 | 0.0056 | 0.0036 |
Plasmodium vivax | glutathione reductase, putative | 0.0037 | 0.0049 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0368 | 0.0383 |
Brugia malayi | Steroid receptor seven-up type 2 | 0.006 | 0.0368 | 0.0368 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0207 | 0.0216 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-49 | 0.006 | 0.0368 | 0.0383 |
Echinococcus multilocularis | hepatocyte nuclear factor 4 alpha | 0.006 | 0.0368 | 0.0399 |
Echinococcus multilocularis | Nuclear hormone receptor family member nhr 41 | 0.006 | 0.0368 | 0.0399 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0093 | 0.0813 | 1 |
Echinococcus granulosus | ecdysone induced protein 78C | 0.006 | 0.0368 | 0.0399 |
Onchocerca volvulus | Bile acid receptor homolog | 0.006 | 0.0368 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0025 | 0.5 |
Schistosoma mansoni | nuclear hormone receptor | 0.006 | 0.0368 | 0.0427 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0037 | 0.0049 | 0.5 |
Plasmodium falciparum | thioredoxin reductase | 0.0037 | 0.0049 | 0.5 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0059 | 0.035 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0037 | 0.0049 | 0.0051 |
Schistosoma mansoni | steroid hormone receptor ad4bp | 0.006 | 0.0368 | 0.0427 |
Schistosoma mansoni | photoreceptor-specific nuclear receptor related | 0.006 | 0.0368 | 0.0427 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.006 | 0.0368 | 0.0399 |
Schistosoma mansoni | coup transcription factor | 0.006 | 0.0368 | 0.0427 |
Echinococcus multilocularis | ecdysone induced protein 78C | 0.006 | 0.0368 | 0.0399 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0668 | 0.8626 | 1 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0375 | 0.4637 | 0.5363 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.0741 | 0.9615 | 0.9615 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.006 | 0.0368 | 0.0399 |
Brugia malayi | Nuclear hormone receptor family member nhr-3 | 0.006 | 0.0368 | 0.0368 |
Brugia malayi | Nuclear hormone receptor family member nhr-41 | 0.006 | 0.0368 | 0.0368 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0059 | 0.035 | 0.0378 |
Brugia malayi | Nuclear hormone receptor family member nhr-40 | 0.006 | 0.0368 | 0.0368 |
Loa Loa (eye worm) | nuclear Hormone Receptor family member | 0.006 | 0.0368 | 0.0383 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0668 | 0.8626 | 1 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0059 | 0.035 | 0.0378 |
Brugia malayi | ecdysteroid receptor | 0.006 | 0.0368 | 0.0368 |
Echinococcus multilocularis | FTZ F1 alpha | 0.006 | 0.0368 | 0.0399 |
Brugia malayi | nuclear hormone receptor | 0.006 | 0.0368 | 0.0368 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0435 | 0.5454 | 0.6312 |
Echinococcus granulosus | retinoic acid receptor rxr beta a | 0.006 | 0.0368 | 0.0399 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0368 | 0.0383 |
Brugia malayi | glutathione reductase | 0.0037 | 0.0049 | 0.0049 |
Schistosoma mansoni | retinoid-x-receptor (RXR) | 0.006 | 0.0368 | 0.0427 |
Mycobacterium tuberculosis | Probable reductase | 0.0084 | 0.0687 | 0.8342 |
Brugia malayi | Nuclear hormone receptor family member nhr-14 | 0.006 | 0.0368 | 0.0368 |
Brugia malayi | hypothetical protein | 0.0035 | 0.0025 | 0.0025 |
Echinococcus granulosus | FTZ F1 alpha | 0.006 | 0.0368 | 0.0399 |
Brugia malayi | Thioredoxin reductase | 0.0037 | 0.0049 | 0.0049 |
Schistosoma mansoni | Tr4/Tr2 (homologue) | 0.006 | 0.0368 | 0.0427 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Relative potency (functional) | = 7 | In vitro antibacterial activity against Escheriachia coli relative to thienamycin | ChEMBL. | No reference |
Relative potency (functional) | = 0.2 | In vitro antibacterial activity against Pseudomonas relative to thienamycin | ChEMBL. | No reference |
Relative potency (functional) | = 1.1 | In vitro antibacterial activity against Staphylococcus aureus relative to thienamycin | ChEMBL. | No reference |
Relative potency (functional) | = 2.3 | In vitro antibacterial activity against Klebsiella relative to thienamycin | ChEMBL. | No reference |
Relative potency (functional) | = 7 | In vitro antibacterial activity against Escheriachia coli relative to thienamycin | ChEMBL. | No reference |
Relative potency (functional) | = 11.3 | In vitro antibacterial activity against Enterobacter relative to thienamycin | ChEMBL. | No reference |
Relative potency (functional) | = 16 | In vitro antibacterial activity against Proteus relative to thienamycin | ChEMBL. | No reference |
Relative potency (functional) | = 24.3 | In vitro antibacterial activity against Enterococcus relative to thienamycin | ChEMBL. | No reference |
Relative potency (functional) | = 29.9 | In vitro antibacterial activity against Serratia relative to thienamycin | ChEMBL. | No reference |
Susceptibility (binding) | = 0.14 | Susceptibility of compound towards porcine Dehydropeptidase-1 relative to imipenem as 0.85 was calculated | ChEMBL. | No reference |
Susceptibility (binding) | = 0.14 | Susceptibility of compound towards porcine Dehydropeptidase-1 relative to imipenem as 0.85 was calculated | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.